Moderna
Information

Moderna

ISIN
US60770K1079
Ticker
MRNA
ISIN
US60770K1079
Ticker
MRNA
New Post
$136.43
+ $1.02
0.75%

Information

large cap stock
Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. The Company develops technologies that enable the development of mRNA medicines for diverse applications. It has created modalities, including prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, and systemic intracellular therapeutics. The Company develops technologies that enable the development of mRNA medicines.
Employees
2,700
Industries
Biotechnology & Drugs
Sector
Health Care

Community

Financials

1D span
$133.71
$136.54
52W span
$119.01
$497.49
Market Cap
$54.02B
Beta
1.69212
Free Float
360.23M
Shares outstanding
397.76M

Analyst Ratings

Target Price
$220.00
This security is covered by 19 analysts
Buy
8
Hold
10
Sell
1

Activities

Trending